Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy
The aim of this study was to determine, through a genome-wide association study (GWAS), the genetic components contributing to different clinical sub-phenotypes of systemic sclerosis (SSc). We considered limited (lcSSc) and diffuse (dcSSc) cutaneous involvement, and the relationships with presence of the SSc-specific auto-antibodies, anti-centromere (ACA), and anti-topoisomerase I (ATA). Four GWAS cohorts, comprising 2,296 SSc patients and 5,171 healthy controls, were meta-analyzed looking for associations in the selected subgroups. Eighteen polymorphisms were further tested in nine independent cohorts comprising an additional 3,175 SSc patients and 4,971 controls. Conditional analysis for associated SNPs in the HLA region was performed to explore their independent association in antibody subgroups. Overall analysis showed that non-HLA polymorphism rs11642873 in IRF8 gene to be associated at GWAS level with lcSSc (P = 2.32×10−12, OR = 0.75). Also, rs12540874 in GRB10 gene (P = 1.27 × 10−6, OR = 1.15) and rs11047102 in SOX5 gene (P = 1.39×10−7, OR = 1.36) showed a suggestive association with lcSSc and ACA subgroups respectively. In the HLA region, we observed highly associated allelic combinations in the HLA-DQB1 locus with ACA (P = 1.79×10−61, OR = 2.48), in the HLA-DPA1/B1 loci with ATA (P = 4.57×10−76, OR = 8.84), and in NOTCH4 with ACA P = 8.84×10−21, OR = 0.55) and ATA (P = 1.14×10−8, OR = 0.54). We have identified three new non-HLA genes (IRF8, GRB10, and SOX5) associated with SSc clinical and auto-antibody subgroups. Within the HLA region, HLA-DQB1, HLA-DPA1/B1, and NOTCH4 associations with SSc are likely confined to specific auto-antibodies. These data emphasize the differential genetic components of subphenotypes of SSc.
Vyšlo v časopise:
Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy. PLoS Genet 7(7): e32767. doi:10.1371/journal.pgen.1002178
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1002178
Souhrn
The aim of this study was to determine, through a genome-wide association study (GWAS), the genetic components contributing to different clinical sub-phenotypes of systemic sclerosis (SSc). We considered limited (lcSSc) and diffuse (dcSSc) cutaneous involvement, and the relationships with presence of the SSc-specific auto-antibodies, anti-centromere (ACA), and anti-topoisomerase I (ATA). Four GWAS cohorts, comprising 2,296 SSc patients and 5,171 healthy controls, were meta-analyzed looking for associations in the selected subgroups. Eighteen polymorphisms were further tested in nine independent cohorts comprising an additional 3,175 SSc patients and 4,971 controls. Conditional analysis for associated SNPs in the HLA region was performed to explore their independent association in antibody subgroups. Overall analysis showed that non-HLA polymorphism rs11642873 in IRF8 gene to be associated at GWAS level with lcSSc (P = 2.32×10−12, OR = 0.75). Also, rs12540874 in GRB10 gene (P = 1.27 × 10−6, OR = 1.15) and rs11047102 in SOX5 gene (P = 1.39×10−7, OR = 1.36) showed a suggestive association with lcSSc and ACA subgroups respectively. In the HLA region, we observed highly associated allelic combinations in the HLA-DQB1 locus with ACA (P = 1.79×10−61, OR = 2.48), in the HLA-DPA1/B1 loci with ATA (P = 4.57×10−76, OR = 8.84), and in NOTCH4 with ACA P = 8.84×10−21, OR = 0.55) and ATA (P = 1.14×10−8, OR = 0.54). We have identified three new non-HLA genes (IRF8, GRB10, and SOX5) associated with SSc clinical and auto-antibody subgroups. Within the HLA region, HLA-DQB1, HLA-DPA1/B1, and NOTCH4 associations with SSc are likely confined to specific auto-antibodies. These data emphasize the differential genetic components of subphenotypes of SSc.
Zdroje
1. AgarwalSKTanFKArnettFC 2008 Genetics and genomic studies in scleroderma (systemic sclerosis). Rheum Dis Clin North Am 34 17 40
2. ArnettFCGourhPSheteSAhnCWHoneyRE 2010 Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls. Ann Rheum Dis 69 822 827
3. ZhouXLeeJEArnettFCXiongMParkMY 2009 HLA-DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in North Americans. Arthritis Rheum 60 3807 3814
4. RuedaBBroenJSimeonCHesselstrandRDiazB 2009 The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype. Hum Mol Genet 18 2071 2077
5. DieudePGuedjMWipffJRuizBHachullaE 2009 STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis. Arthritis Rheum 60 2472 2479
6. TsuchiyaNKawasakiAHasegawaMFujimotoMTakeharaK 2009 Association of STAT4 polymorphism with systemic sclerosis in a Japanese population. Ann Rheum Dis 68 1375 1376
7. DieudePGuedjMWipffJAvouacJFajardyI 2009 Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis. Arthritis Rheum 60 225 233
8. ItoIKawaguchiYKawasakiAHasegawaMOhashiJ 2009 Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population. Arthritis Rheum 60 1845 1850
9. GourhPAgarwalSKMartinEDivechaDRuedaB 2010 Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations. J Autoimmun 34 155 162
10. ItoIKawaguchiYKawasakiAHasegawaMOhashiJ 2010 Association of the FAM167A-BLK region with systemic sclerosis. Arthritis Rheum 62 890 895
11. DieudePWipffJGuedjMRuizBMelchersI 2009 BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4. Arthritis Rheum 60 3447 3454
12. RuedaBGourhPBroenJAgarwalSKSimeonC 2010 BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians. Ann Rheum Dis 69 700 705
13. GourhPArnettFCTanFKAssassiSDivechaD 2010 Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis. Ann Rheum Dis 69 550 555
14. Bossini-CastilloLBroenJCSimeonCPBerettaLVonkMC 2011 A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort. Ann Rheum Dis 70 638 641
15. RadstakeTRGorlovaORuedaBMartinJEAlizadehBZ 2010 Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet 42 426 429
16. JimenezSADerkCT 2004 Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Intern Med 140 37 50
17. LeRoyECMedsgerTAJr 2001 Criteria for the classification of early systemic sclerosis. J Rheumatol 28 1573 1576
18. GabrielliAAvvedimentoEVKriegT 2009 Scleroderma. N Engl J Med 360 1989 2003
19. SteenVD 2008 The many faces of scleroderma. Rheum Dis Clin North Am 34 1 15
20. NietertPJMitchellHCBolsterMBShaftmanSRTilleyBC 2006 Racial variation in clinical and immunological manifestations of systemic sclerosis. J Rheumatol 33 263 268
21. AssassiSArnettFCReveilleJDGourhPMayesMD 2007 Clinical, immunologic, and genetic features of familial systemic sclerosis. Arthritis Rheum 56 2031 2037
22. ArnettFCGourhPSheteSAhnCWHoneyR 2009 Major Histocompatibility Complex (MHC) class II alleles, haplotypes, and epitopes which confer susceptibility or protection in the fibrosing autoimmune disease systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls. Ann Rheum Dis 69 5 822 7
23. GourhPTanFKAssassiSAhnCWMcNearneyTA 2006 Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis. Arthritis Rheum 54 3945 3953
24. HardieWDKorfhagenTRSartorMAPrestridgeAMedvedovicM 2007 Genomic profile of matrix and vasculature remodeling in TGF-alpha induced pulmonary fibrosis. Am J Respir Cell Mol Biol 37 309 321
25. SilverRMMillerKSKinsellaMBSmithEASchabelSI 1990 Evaluation and management of scleroderma lung disease using bronchoalveolar lavage. Am J Med 88 470 476
26. RubinLJ 1997 Primary pulmonary hypertension. N Engl J Med 336 111 117
27. ZhernakovaAStahlEATrynkaGRaychaudhuriSFestenEA 2011 Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet 7 e1002004 doi:10.1371/journal.pgen.1002004
28. ValdesAMThomsonG 2009 Several loci in the HLA class III region are associated with T1D risk after adjusting for DRB1-DQB1. Diabetes Obes Metab 11 Suppl 1 46 52
29. KochiYYamadaRKobayashiKTakahashiASuzukiA 2004 Analysis of single-nucleotide polymorphisms in Japanese rheumatoid arthritis patients shows additional susceptibility markers besides the classic shared epitope susceptibility sequences. Arthritis Rheum 50 63 71
30. Tazi-AhniniRCorkMJWengrafDWilsonAGGawkrodgerDJ 2003 Notch4, a non-HLA gene in the MHC is strongly associated with the most severe form of alopecia areata. Hum Genet 112 400 403
31. PetukhovaLDuvicMHordinskyMNorrisDPriceV 2010 Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 466 113 117
32. AssassiSMayesMDArnettFCGourhPAgarwalSK 2010 Systemic sclerosis and lupus: points in an interferon-mediated continuum. Arthritis Rheum 62 589 598
33. TrinchieriG 2010 Type I interferon: friend or foe? J Exp Med 207 10 2053 2063
34. ElorantaMLFranck-LarssonKLovgrenTKalamajskiSRonnblomA 2010 Type I interferon system activation and association with disease manifestations in systemic sclerosis. Ann Rheum Dis 69 1396 1402
35. ZhaoJKongHJLiHHuangBYangM 2006 IRF-8/interferon (IFN) consensus sequence-binding protein is involved in Toll-like receptor (TLR) signaling and contributes to the cross-talk between TLR and IFN-gamma signaling pathways. J Biol Chem 281 10073 10080
36. WangHLeeCHQiCTailorPFengJ 2008 IRF8 regulates B-cell lineage specification, commitment, and differentiation. Blood 112 4028 4038
37. De JagerPLJiaXWangJde BakkerPIOttoboniL 2009 Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 41 776 782
38. LefebvreVBehringerRRde CrombruggheB 2001 L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway. Osteoarthritis Cartilage 9 Suppl A S69 75
39. BobickBEMatscheAIChenFHTuanRS 2010 The ERK5 and ERK1/2 signaling pathways play opposing regulatory roles during chondrogenesis of adult human bone marrow-derived multipotent progenitor cells. J Cell Physiol 224 178 186
40. OsakiMTanLChoyBKYoshidaYCheahKS 2003 The TATA-containing core promoter of the type II collagen gene (COL2A1) is the target of interferon-gamma-mediated inhibition in human chondrocytes: requirement for Stat1 alpha, Jak1 and Jak2. Biochem J 369 103 115
41. KannoYLeviBZTamuraTOzatoK 2005 Immune cell-specific amplification of interferon signaling by the IRF-4/8-PU.1 complex. J Interferon Cytokine Res 25 770 779
42. NantelAMohammad-AliKSherkJPosnerBIThomasDY 1998 Interaction of the Grb10 adapter protein with the Raf1 and MEK1 kinases. J Biol Chem 273 10475 10484
43. SimeonCPFonollosaVTolosaCPalouESelvaA 2009 Association of HLA class II genes with systemic sclerosis in Spanish patients. J Rheumatol 36 2733 2736
44. HunterDJKraftPJacobsKBCoxDGYeagerM 2007 A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39 870 874
45. YeagerMOrrNHayesRBJacobsKBKraftP 2007 Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 39 645 649
46. 1980 Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23 581 590
47. LeRoyECBlackCFleischmajerRJablonskaSKriegT 1988 Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15 202 205
48. MarchiniJHowieBMyersSMcVeanGDonnellyP 2007 A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 39 906 913
49. SkolADScottLJAbecasisGRBoehnkeM 2006 Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38 209 213
50. BarrettJCFryBMallerJDalyMJ 2005 Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 263 265
51. PurcellSNealeBTodd-BrownKThomasLFerreiraMA 2007 PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81 559 575
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2011 Číslo 7
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
Najčítanejšie v tomto čísle
- Genome-Wide Association Study Identifies Novel Restless Legs Syndrome Susceptibility Loci on 2p14 and 16q12.1
- Loss of the BMP Antagonist, SMOC-1, Causes Ophthalmo-Acromelic (Waardenburg Anophthalmia) Syndrome in Humans and Mice
- Gene-Based Tests of Association
- Genome-Wide Association Study Identifies as a Susceptibility Gene for Pediatric Asthma in Asian Populations